Endonovo is a California-based biotechnology company that develops and commercializes electroceutical therapies for the treatment of cardiovascular diseases.
Business Model:
Revenue: $14.2k
Employees: 1-1
Address: 6320 Canoga Avenue
City: Woodland Hills
State: CA
Zip: 91367
Country: US
Endonovo is a California-based biotechnology company that develops and commercializes electroceutical therapies for the treatment of cardiovascular diseases.
Contact Phone:
+18007011223
Contact Email:
Listed Exchange:
OTCBB
IPO Date:
11/7/2014
Ticker Symbol:
ENDV
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2016 | Post-IPO Debt | $5M | 11/2014 | Unattributed | $105k | 8/2014 | Debt Financing | $483k | 1/2016 | Equity | $211.3k | 7/2016 | Post-IPO Equity | $10M | 10/2019 | Equity | $225k | 12/2017 | Equity | $700k |
---|
Announced Date | Name | Price |
---|---|---|
7/2016 | Rio Grande Neurosciences |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|